期刊文献+

参仙升脉液对离体大鼠心脏工作模型血液动力学的影响 被引量:3

The Effect of Shenxian Shengmai Liquid on the Hemodynamics of Isolated Work Model of Rat Heart
暂未订购
导出
摘要 参仙升脉液是主治病态窦房结综合征的中药复方制剂。经临床近300例患者验证结果,总有效率达90%左右,平均每min提高心率10-15次。本文为研究该药的作用机理,采用离体大鼠心脏灌注工作模型,观察经超滤后的参仙升脉液对血流动力学各指标的影响。结果提示该药有降低冠脉血管阻力(26.9±24%),增加冠脉流量(34.6±3.9%)和提高心率(26.6±1.4%)的作用。用药后主动脉流量减少,对心输出量及舒张压无明显影响。这可能与该药引起心输出量的再分配有关。 Shenxian Sliengniai Liquid(SSL) is a herbal preparation for the treatment of sick sinussyndrome(SSS), which is manufactured by ultrafiltration. Through the clinical observation of nearly 300cases of SSS, its total effective rate was 90.00% and the heart rate was increased byl 0 to 15 beats per minutein average, For the study of its therapeutic mechanism, the isolated work model of rat heart was employedand its effect on various criteria of hemodynamics was observed. The results showed that the coronaryvascular resistance was significantly reduced (26.9 ± 2.4%), the coronary blood flow was increased (34.6 ±3.9%and the heart rate was also increased(28.6 ± 4. 1%).The blood low in the aorta was reduced,while thecardiac output and the diastolic blood pressure were not affected. It is suggested that the therapeulic mecha-nism of SST is possibly related to the redistribution of the cardiac output.
机构地区 北京中医药大学
出处 《中药新药与临床药理》 CAS CSCD 1995年第2期20-21,共2页 Traditional Chinese Drug Research and Clinical Pharmacology
关键词 参仙升脉液 药理学 动物模型 血液动力学 Shenxian Shengniai Liquidlpharmacology sick sinus syndromelthcrapy , TCM Yang Deficiencyltherapy, TCM perfusion Hemodynamics
  • 相关文献

同被引文献27

  • 1许爱华,许丽丽,徐小兵,李焱,张洪泉,施雪筠,龙致贤,刘爱銮.参仙升脉液对小鼠细胞免疫功能的促进作用[J].中药新药与临床药理,1995,6(2):45-46. 被引量:3
  • 2杨跃进,华伟.阜外心血管内科手册[M].北京:人民卫生出版社,2008.394.
  • 3陈灏珠.实用内科学[M].北京:人民卫生出版社,2009.
  • 4陆再英,钟南山.内科学[M].北京:人民卫生出版社,2009:493.
  • 5陆再英,钟南山内科学[M].北京:人民卫生出版社,2008:179-181.
  • 6周仲英.中医内科学[M].北京:中国中医药出版社,2009:38.
  • 7郑莜萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.143-150.
  • 8黄宛.临床心电学[M].北京:人民卫生出版社,1998.79-90.
  • 9Verdecchia P , Carini G, Circo A , et al . Left ventric- ular mass and car 2diovascular morbidity in essential hypertension : the MAVI study[J]. Am Coil Cardiol , 2001 , 38(7) :1 829.
  • 10Spirito P , Bellone P , Harris KM, et al. Magnitude of left ventricular hy2pertrophy and risk of sudden death in hy- pertrophic cardiomyopathy[J]. nEngl J Med , 2000 , 342 (24) :1778.

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部